Cargando...
Converting biology into clinical benefit: lessons learned from BRAF inhibitors
The identification and pharmacological targeting of activating BRAF mutations in melanoma has led to significant improvements in patient outcomes. This perspective paper illustrates the lessons learned from the study of BRAF mutations and the development of BRAF inhibitors. The relevance of these le...
Gardado en:
| Publicado en: | Melanoma Manag |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Future Medicine Ltd
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4649930/ https://ncbi.nlm.nih.gov/pubmed/26594316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt.15.18 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|